Sign in
FWBI Stock Price, Chart, Stats & News
First Wave BioPharma, Inc.
Save
5.99M
Market cap
–
Current P/E
–
Forward P/E
FWBI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.00% |
Operating margin | 910.80% |
Pretax margin | 3345.63% |
Net margin | 14054.07% |
Effective tax rate | -320.07% |
ROA | -14.41% |
ROE | -624.65% |
D/E | 0.03x |
Interest coverage ratio | 22.68x |
FWBI valuation
P/E | – |
P/S | -43.20x |
P/B | 0.18x |
P/CF | -11.39x |
P/FCF | 85.00x |
P/OCF | -11.39x |
PEG | 0.03x |
EV multiple | -2.06x |
About
First Wave BioPharma, Inc. is a biopharmaceutical company in the clinical development phase, concentrating on the research and creation of specialized, non-systemic treatments for various gastrointestinal conditions. The company's therapeutic pipeline centers on two main compounds: 1. Niclosamide: An oral small molecule recognized for its antiviral and anti-inflammatory properties.
Similar securities
Based on sector and market capitalization
Report issue